Q1 FY2026 EarningsQ2 FY26 results significantly missed consensus estimates on the top line and margins, despite a technical beat on EPS caused by massive share dilution. Revenue of $1.56M fell 69.75% short of the $5.16M expected, while gross margin collapsed to 13.20% compared to the 69.00% mean estimate. The variance was driven by a pivot to a high-cost teleradiology contractor model and significant client attrition in legacy Tele-ICU services. Management issued a going concern warning and confirmed the stock's delisting from Nasdaq as of August 6, 2026.
Financial report interval: 2025.12.31 - 2026.03.31
Overview: VSee Health(VSEE) the Revenue is 3.16 M (-4.86%);the EBIT is -2.974 M (-62.41%);the EPS is -0.0543 (+77.64%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B4.86%
----
----
EBIT
-0.00B62.41%
----
----
EPS
-0.054377.64%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf